Skip to main content

Marta Comas Martínez

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Marta Comas Martínez

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

¿CONOCER LA PREDISPOSICIÓN GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?

IP: -
Collaborators: Marta Comas Martínez, Enzamaría Fidilio Meli
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI21/00462
Duration: 01/01/2022 - 30/06/2026

Utilidad del TAC abdominal e inteligencia artificial para la evaluación de la composición corporal y condición metabólica en sujetos con obesidad: estudio FLASH

IP: Andreea Ciudin Mihai
Collaborators: Manuel Escobar Amores, Nuria Roson Gradaille, Fiorella Ximena Palmas Candia, Aitor Rodriguez Martinez, Marta Comas Martínez, Enzamaría Fidilio Meli
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 431460
Reference: CPP2023-010524
Duration: 01/11/2024 - 30/10/2027

Ministerio de Ciencia

Mechanisms of metabolic adaptation after weight loss in obesity. Clinical phenotyping and therapeutic approach.

IP: Andreea Ciudin Mihai
Collaborators: Cristina Gamez Cenzano, Eduard Rodenas Alesina, Ana Marti Delgado, Fiorella Ximena Palmas Candia, Bruno García del Blanco, Ana Belén Méndez Fernández, Ana Maria Ciscar Bellés, Aleix Olivella San emeterio, Marta Comas Martínez, Alvaro Calabuig Goena, Enzamaría Fidilio Meli, Marco Tomasino
Funding agency: Instituto de Salud Carlos III
Funding: 165000
Reference: PI23/01209
Duration: 01/01/2024 - 31/12/2026

BIO-STREAM: Multi-Pillar Framework for children Anti-Obesity Behavior building on an EU biobank, Micro Moments and Mobile Recommendation Systems

IP: Andreea Ciudin Mihai
Collaborators: Marta Comas Martínez, Graciela Gastelum Varela, José Raul Herance Camacho
Funding agency: EUROPEAN COMMISSION
Funding: 317500
Reference: BIO-STREAM_HE-HLTH-STAYHLTH2022
Duration: 01/05/2023 - 30/04/2027

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Related professionals

Sara Garcia Ortega

Sara Garcia Ortega

Predoctoral researcher
Translational Molecular Pathology
Read more
Paula Isabel Roldan Caballero

Paula Isabel Roldan Caballero

Research Support. Licensed Technician
Clinical Research Development Directorate
Read more
Martina Garriga Ferrer

Martina Garriga Ferrer

Gestor/a. Nivell 3.2
Internal Strategy Directorate
Read more
Beatriz  Soria Navarro

Beatriz Soria Navarro

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.